Insulin and Glucagon — Revision Notes

⚡ 30-Second Revision

Insulin: — Secreted by Beta cells (pancreas). Stimulus: High blood glucose. Effect: Lowers blood glucose. Actions: Glucose uptake (muscle/adipose via GLUT4), Glycogenesis (liver/muscle), Lipogenesis, Protein synthesis. Anabolic hormone.
Glucagon: — Secreted by Alpha cells (pancreas). Stimulus: Low blood glucose. Effect: Raises blood glucose. Actions: Glycogenolysis (liver), Gluconeogenesis (liver), Lipolysis. Catabolic hormone.
Islets of Langerhans: — Endocrine part of pancreas, contains $\alpha$, $\beta$, $\delta$ cells.
C-peptide: — Co-secreted with insulin, marker of endogenous insulin production.
Diabetes Mellitus: — T1DM (insulin deficiency), T2DM (insulin resistance).

2-Minute Revision

Insulin and glucagon are the two primary hormones maintaining blood glucose balance, both originating from the pancreatic islets of Langerhans. Insulin, secreted by beta cells in response to high blood glucose (e.

g., after a meal), acts to lower blood sugar. It achieves this by promoting glucose uptake into muscle and fat cells (via GLUT4 transporters), stimulating the liver and muscles to convert glucose into stored glycogen (glycogenesis), and encouraging fat synthesis (lipogenesis).

Insulin is fundamentally an anabolic hormone, building up energy reserves. Conversely, glucagon, secreted by alpha cells when blood glucose is low (e.g., during fasting), works to raise blood sugar. Its main target is the liver, where it stimulates the breakdown of stored glycogen into glucose (glycogenolysis) and the creation of new glucose from non-carbohydrate sources (gluconeogenesis).

Glucagon also promotes fat breakdown (lipolysis). It is a catabolic hormone, mobilizing stored energy. The precise, antagonistic actions of insulin and glucagon are crucial for preventing metabolic imbalances like hyperglycemia and hypoglycemia, which are central to understanding diabetes mellitus.

5-Minute Revision

The dynamic interplay between insulin and glucagon is the cornerstone of glucose homeostasis, ensuring a stable energy supply for the body. Both hormones are produced in the pancreatic islets of Langerhans, but by different cell types. Insulin, a peptide hormone, is secreted by the beta cells primarily in response to elevated blood glucose (e.g., after a carbohydrate-rich meal), amino acids, and incretins. Its main goal is to lower blood glucose. Insulin achieves this by:

1
Increasing glucose uptake: — In muscle and adipose tissue, it triggers the translocation of GLUT4 transporters to the cell membrane, allowing more glucose to enter cells.
2
Promoting glycogenesis: — Stimulates the synthesis of glycogen (stored glucose) in the liver and muscles.
3
Promoting lipogenesis: — Encourages the conversion of excess glucose into fatty acids and their storage as triglycerides in adipose tissue and liver.
4
Promoting protein synthesis: — Enhances amino acid uptake and protein formation.
5
Inhibiting glucose production: — Suppresses glycogenolysis and gluconeogenesis in the liver.

Insulin is thus an anabolic hormone, promoting storage and synthesis.

Glucagon, also a peptide hormone, is secreted by the alpha cells primarily in response to low blood glucose (e.g., during fasting or intense exercise) and amino acids. Its main goal is to raise blood glucose. Glucagon primarily targets the liver and acts by:

1
Stimulating glycogenolysis: — Rapidly breaks down stored liver glycogen into glucose, releasing it into the bloodstream.
2
Stimulating gluconeogenesis: — Promotes the synthesis of new glucose from non-carbohydrate precursors (lactate, amino acids, glycerol) in the liver.
3
Promoting lipolysis: — Breaks down triglycerides in adipose tissue, releasing fatty acids and glycerol for energy or gluconeogenesis.

Glucagon is a catabolic hormone, mobilizing stored energy.

The balance between these two hormones is a classic negative feedback loop. High glucose leads to insulin release, lowering glucose. Low glucose leads to glucagon release, raising glucose. Disruptions in this balance lead to conditions like Diabetes Mellitus: Type 1 (absolute insulin deficiency due to beta cell destruction) and Type 2 (insulin resistance and/or impaired insulin secretion).

C-peptide, co-secreted with insulin, is a useful clinical marker for endogenous insulin production.

Prelims Revision Notes

Insulin and Glucagon: NEET Quick Recall

1. Pancreatic Islets of Langerhans:

Alpha ($\alpha$) cells: — Secrete Glucagon.
Beta ($\beta$) cells: — Secrete Insulin and Amylin.
Delta ($\delta$) cells: — Secrete Somatostatin (inhibits both insulin and glucagon).

2. Insulin (The 'Storage' Hormone):

Origin: — Beta cells.
Stimulus for Release: — High blood glucose (primary), amino acids, fatty acids, incretins (GLP-1, GIP), parasympathetic stimulation.
Primary Effect: — Lowers blood glucose (hypoglycemic).
Overall Role: — Anabolic hormone (promotes storage and synthesis).
Target Tissues: — Liver, muscle, adipose tissue.
Key Actions:

* Glucose Uptake: Increases glucose uptake into muscle and adipose cells by translocating GLUT4 transporters to the cell membrane. (Note: Liver uses GLUT2, which is insulin-independent for basal uptake, but insulin influences liver glucose metabolism).

* Glycogenesis: Stimulates synthesis of glycogen in liver and muscle. * Lipogenesis: Promotes synthesis of fatty acids and triglycerides from glucose in liver and adipose tissue; inhibits lipolysis.

* Protein Synthesis: Promotes amino acid uptake and protein synthesis. * Inhibition: Inhibits gluconeogenesis and glycogenolysis in the liver.

C-peptide: — Co-secreted with insulin; used as a marker for endogenous insulin production.

3. Glucagon (The 'Mobilization' Hormone):

Origin: — Alpha cells.
Stimulus for Release: — Low blood glucose (primary), amino acids, sympathetic stimulation.
Primary Effect: — Raises blood glucose (hyperglycemic).
Overall Role: — Catabolic hormone (mobilizes stored energy).
Target Tissues: — Primarily Liver.
Key Actions:

* Glycogenolysis: Stimulates breakdown of liver glycogen to glucose. * Gluconeogenesis: Stimulates synthesis of new glucose from non-carbohydrate precursors (lactate, amino acids, glycerol) in the liver. * Lipolysis: Promotes breakdown of triglycerides in adipose tissue, releasing fatty acids and glycerol.

4. Glucose Homeostasis:

Maintained by the antagonistic actions of insulin and glucagon via a negative feedback loop.
High glucose $\rightarrow$ Insulin $\rightarrow$ Lower glucose.
Low glucose $\rightarrow$ Glucagon $\rightarrow$ Raise glucose.

5. Clinical Relevance (Diabetes Mellitus):

Type 1 Diabetes (T1DM): — Autoimmune destruction of beta cells $\rightarrow$ Absolute insulin deficiency. Requires exogenous insulin.
Type 2 Diabetes (T2DM): — Insulin resistance (target cells don't respond) and/or impaired insulin secretion. Often managed with lifestyle, oral medications, or insulin.

Vyyuha Quick Recall

In Storage, Glucose Up!

Insulin: Storage (glycogen, fat), Glucose Uptake (into cells). Lowers blood sugar.

Gone Glucose? Get Glucagon!

Gone Glucose (low blood sugar): Get Glucagon (to raise it).
Glucagon: Glycogenolysis, Gluconeogenesis. Raises blood sugar.